MarketPeel
Insider Trading Intelligence
JF

Jonathan Finn

ATOS
DIRECTOR · ATOSSA THERAPEUTICS, INC. · CIK 0001981595
FILING MIX · LIFETIME100%/0%
BUYS
14
SELLS
0
TOTAL VALUE
$44.3K
COMPANIES
2
ACTIVE SINCE
May 2023
HOLDINGS NOW
12,872
AVG SELL PX
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jonathan Finn, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-22.86%-2.64%-20.22%-20.22%
14d1+0.00%-14.29%-1.69%-12.59%-12.59%
30d1+0.00%-14.86%+1.31%-16.16%-16.16%
60d1+0.00%-31.43%+4.19%-35.62%-35.62%
90d1+0.00%-34.29%+8.46%-42.75%-42.75%
180d1+0.00%-18.86%+11.14%-29.99%-29.99%
1y1+0.00%-66.29%+3.33%-69.62%-69.62%
2y1+0.00%-81.18%+33.84%-115.02%-115.02%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ATOS · 11,666 shares · as of May 12, 2026
031,25062,50093,750125,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 0 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ATOS
ATOSSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00011,666May 12, 2026May 14, 2026View →
ATOS
ATOSSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
125,000125,000May 15, 2025May 16, 2025View →
ATOS
ATOSSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
125,000125,000Jun 27, 2024Jul 1, 2024View →
ATOS
ATOSSA THERAPEUTICS, INC.
PURCHASE
25,000$1.77$44.3K25,000Apr 10, 2024Apr 11, 2024View →
ATOS
ATOSSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
62,50062,500Nov 15, 2023Nov 15, 2023View →
ATOS
ATOSSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
62,50062,500Nov 15, 2023Nov 15, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
1,505,9671,505,967May 31, 2023Jun 12, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
12,0481,518,015May 31, 2023Jun 12, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
13,4051,277,453May 31, 2023Jun 12, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
118,8931,264,048May 31, 2023Jun 12, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
1,143,9491,145,155May 31, 2023Jun 12, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
12,0481,518,015May 31, 2023Jun 12, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
1,505,9671,505,967May 31, 2023Jun 12, 2023View →
CBUS
CIBUS, INC.
PURCHASEGRANT
Stock grant
1,2061,206May 31, 2023Jun 12, 2023View →
Other insiders · ATOS
Loading peer insiders…
About this filer
CIK 0001981595
ROLE
Director
PRIMARY
ATOS
COMPANIES
2
ACTIVE SINCE
May 2023
MARKETPEEL · /INSIDER/0001981595DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback